Emmessar Biotech & Nutrition Ltd Stock Analysis

BSE: 524768 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price 31-Mar-2023 14:11
24.80 -0.12 (-0.48%)

DeciZen - Make an Informed Decision on Emmessar Biotech&Nut

M-Cap below 100cr DeciZen not available

Emmessar Biotech&Nut Price Chart

P/E Ratio ( SA) :
36.51
Market Cap :
12.5 Cr.
52-wk low :
18.5
52-wk high :
47.4
Bole Toh?

1. Is Emmessar Biotech & Nutrition Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Emmessar Biotech & Nutrition Ltd is a average quality company.

2. Is Emmessar Biotech & Nutrition Ltd undervalued or overvalued?

The key valuation ratios of Emmessar Biotech & Nutrition Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Emmessar Biotech & Nutrition Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Emmessar Biotech & Nutrition Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Emmessar Biotech&Nut:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Emmessar Biotech & Nutrition Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
ROCE % -8.8%-17%-8%15.7%79.1%36.1%22.4%23.9%29.1%5%-
Value Creation Index -1.6-2.2-1.60.14.71.60.60.71.1-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.61.42.222.61.30.63.470.41
YoY Gr. Rt. %-136.2%59.9%-10.1%33.5%-52.5%-49.6%439.7%105.6%-94.9%-
Adj EPS -0.4-0.6-0.20.42.41.81.51.92.90.60.7
YoY Gr. Rt. %-NANANA555.6%-22.5%-19.7%27.9%54.3%-79.7%-
BVPS (₹) 3.83.22.81.84.2678.511.412.413
Adj Net Profit -0.2-0.3-0.10.21.20.90.70.91.50.30
Cash Flow from Ops. 0000.40.80.70.410.52.3-
Debt/CF from Ops. 0000000.2000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -5.2%-32.8%-17%-94.9%
Adj EPS NA-24.2%-26.2%-79.7%
BVPS 14.124.220.78.2
Share Price 21.6% -4.2% 29.6% -9.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
Return on Equity % -8.9-17.1-8.115.678.63622.624.129.155.4
Op. Profit Mgn % -32.9-3.9-6.50.68.6-33.3-101.6-11.912.1-242.4-83.9
Net Profit Mgn % -31.4-22-5.5944.872.9116.527.620.780.940
Debt to Equity 0000000000-
Working Cap Days 1,8284771261751523339051931242,0440
Cash Conv. Cycle 362766364403918747571,3470

Recent Performance Summary

Sales growth is good in last 4 quarters at 274.27%

Return on Equity has declined versus last 3 years average to 5.40%

Sales growth has been subdued in last 3 years -17.02%

Net Profit has been subdued in last 3 years -26.24%

Latest Financials - Emmessar Biotech & Nutrition Ltd.

Standalone Consolidated
TTM EPS (₹) 0.7 -
TTM Sales (₹ Cr.) 0.9 -
BVPS (₹.) 13 -
Reserves (₹ Cr.) 1 -
P/BV 1.92 -
PE 36.51 -
From the Market
52 Week Low / High (₹) 18.50 / 47.40
All Time Low / High (₹) 1.00 / 55.65
Market Cap (₹ Cr.) 12.5
Equity (₹ Cr.) 5
Face Value (₹) 10
Industry PE 36

Management X-Ray of Emmessar Biotech&Nut :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Emmessar Biotech&Nut

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

News

Emmessar Biotech & Nutrition Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Emmessar Biotech&Nut on 31-Mar-2023 14:11 is : 24.80.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Mar-2023 14:11 the market cap of Emmessar Biotech&Nut stood at ₹ 12.45.
The latest PE ratio of Emmessar Biotech&Nut as of 31-Mar-2023 14:11 is 36.51.
The latest PB ratio of Emmessar Biotech&Nut as of 31-Mar-2023 14:11 is 1.92
The 52-week high of Emmessar Biotech&Nut is ₹ 47.40 and the 52-week low is ₹ 18.50.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Emmessar Biotech&Nut is ₹ 0.85 ( Cr.) .

About Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on  March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on  January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi .

When there was a realisation that some of the Speciality Chemicals developed in our R&D and exported to USA & Europe were being used in Healthcare formulations, the Company decided to re-orient itself and enter the Healthcare business, which is poised for phenomenal growth in the coming decades.

Concurrently the company also realised that some of the Speciality Chemicals are actually Vital Micro Nutrients, which are being used in the research worldwide as tools of Biotechnology, the Company took a conscious decision to enter the field of Biotechnology & Healthcare.

To ensure that the name is representative of its activity, the company's name was changed from Emmessar Chemical Industries Ltd., to Emmessar Biotech & Nutrition Ltd., on 7th April 2000.

In the process of pursuing its own R&D and exploring commercial market potentials for their products in the field of Healthcare, the company came across another reputed company in USA Vibrant Life in California.

Intense exchange of ideas & technical information between Emmessar Biotech & Nutrition Ltd., & Vibrant Life, resulted in development of several new concepts and new technologies - combining different schools of thought such as Nutraceuticals, Cosmeceuticals, Ayurveda & Biotechnology.

The company has developed many products covering different areas of healthcare that include obstinate Skin problems & debilitating chronic physical ailments.

Emmessar Biotech & Nutrition Ltd., is a Public Limited Company, with the Paid-up Share Capital of about Rs. 50.00 million (over $ 1.00 million). The Stocks of Emmessar Biotech & Nutrition Ltd., are traded in The Bombay Stock Exchange Ltd.

Product range of the company includes:

Present products

  • Calmcream 
  • Magicream 
  • Supportt Joint  
  • Supportt Bones
  • Micro Nutrients 
  • Speciality Chemicals
  • CC-99  
  • Biosulf  
  • Calmcream  

Products planned to be launched in future

  • Ayurvedic Creams  
  • Nutraceutical Creams
  • Cosmeceutical Creams  
  • Oral Supplements  
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now